Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity, reactogenicity and safety of Influvac 2009/2010 in adults and elderly
2009-010900-27Phase 3Completed
- Sponsor
- Solvay
- Start
- Mar 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of influenza vaccine in influenza (2 arms), sponsored by Solvay. Primary endpoint: Hemagglutination inhibition (HI) antibody titers. Started Mar 2009; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2009-010900-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010900-27.